►
From YouTube: Boulder County Regional Opioid Council (April 2023)
Description
Sixth meeting of the Boulder County Regional Opioid Council (BCROC). Recorded April 24, 2023. For more information on Region 6 Opioids Abatement activities, visit: https://boco.org/Region-6-Opioids-Council
A
A
So
that's
that's
conflicting
with
this
meeting
and
then
Boulder
City
manager,
neria
will
will
also
not
be
able
to
attend
today,
but
I
leave
I.
Believe
we've
got
everyone
else.
B
Great
thanks,
Robin,
let's
give
me
two
seconds
here.
This
is
a
little
bit
of
a
different
format.
Can
everyone
see
my
slides,
yep?
Okay,
perfect
so,
as
Robin
mentioned,
welcome
to
the
April
meeting
of
the
Boulder
County
opioid
Regional
Council,
so
as
just
a
quick
recap
of
our
agenda
today
and
we're
going
to
start
with
our
virtual
meeting
guidelines.
So
you
know
first
and
foremost,
thank
you
to
any
members
of
the
public
that
are
joining
us
here
today.
B
As
this
is
a
pub.
This
is
a
public
meeting,
but
not
a
public
hearing,
so
we
are
not
allowing
for
public
comment
or
interaction
in
the
course
of
conversation.
B
We
do
welcome
any
comments,
concerns
sort
of
questions
to
be
put
into
the
chat,
but
with
recognition
that
it
will
not
be
formally
introduced
into
the
course
of
the
conversation
with
the
council
members
today,
so
for
our
agenda
today,
we're
going
to
start
with
a
discussion
of
current
opioid
trends
that
are
going
on
across
our
region
and
by
Commander
Nico
goldberger,
with
Boulder
County,
Sheriff's
Office
and
the
drug
task
force.
B
We're
also
going
to
follow
up
on
some
conversation
that
we
started
in
our
March
meeting
around
the
possibility
to
test
Wastewater
in
the
region
for
opioids
and
what
that
might
tell
us
what
the
scope
of
that
might
look
like.
Etc
I
will
be
giving
an
update
on
our
selection
process
for
our
request
for
proposal.
B
C
That
would
be
perfect.
Thank
you
very
much.
We
can
move
to
the
odm
app
good
afternoon.
Everyone
I
wanted
to
give
you
a
little
brief,
update
and
understanding
of
what
OD
map
does
for
Boulder
County
as
a
community
itself,
with
this
helping
with
public
health
and
other
treatment
and
preventative
options
out
there.
So
OB
map
was
designed
by
a
high
intensity,
drug
trafficking,
Association
out
east.
It's
a
federal
entity
that
law
enforcement
medical
responders
as
well
as
emergency
departments.
Eds
can
input
information,
and,
let
me
let
me
backtrack.
C
I
want
to
talk
about
the
information
I'm
talking
about
is
information
of
people
who
have
either
passed
away
or
were
saved
by
the
use
of
naloxone
or
other
medical
resources.
So
I
want
to
say
we're
talking
about
lives
here.
So
when
I
say
data
I
do
it
with
all
the
respect,
because
people
have
passed
away
when
we're
dealing
with
this
platform,
so
how
this
works
is
when
law
enforcement.
At
this
point
law
enforcement
responds
to
an
incident,
they
can
add
data
information
into
OD
map.
C
This
gives
us
a
live
time
opportunity
to
see
what
is
occurring
in
our
County,
because
all
the
law
enforcement
agencies
in
Boulder
County
are
signed
up
for
this
I'd
like
to
say
that
Boulder
County
is
the
only
County
in
all
of
Colorado,
where
every
law
enforcement
entity
has
signed
up
we're.
Also
the
DA's
office
coroner's
office
working
on
the
Mobile
County
Public
Health
they're
working
out
some
of
the
minutia
on
getting
that
going,
so
this
county
is
actually
up
to
speed
and
really
doing
well
on
that.
C
So
I
give
your
attention
to
the
map
that
you
see
in
front
of
you
on
the
right
side
is
the
legend.
The
diamonds
indicate
that
somebody
has
died.
The
circles
indicate
that
somebody
did
not
die.
The
different
color
coding
shows
that
whether
naloxone
was
used.
One
of
the
common
trading
Mark
names
is
Narcan
another
one
out.
There
is
clocksado,
but
Narcan
is
a
word
that
you've
seen
or
heard
many
times
so
the
diamonds
do
show
the
deaths
and
whether
Narcan
was
used
not
used.
C
How
many
Administrations
the
bottom
left
shows
you
a
few
numbers
total
suspected
overdoses.
Now
these
this
is
not
official.
It
does
not
come
from
the
coroner's
office.
This
information
is
showing
that
when
law
enforcement
responded
on
the
scene,
they
suspect
that
probably
some
type
of
Overdose,
whether
it
was
let's
say,
fentanyl
or
another,
drug
alcohol
or
anything
else
if
they
think
it
was
present
currently
year
to
date,
that
number
would
be
indicating
46
persons.
C
The
next
part
you
see
down,
there
is
fatal
right
now,
year
to
date,
there
are
10
suspected
fatal
overdoses
again,
not
official
until
the
coroner's
office
give
us
their
information
and
lastly,
at
the
bottom
is
the
naloxone
use.
So
whether
law
enforcement
responded
or
somebody
a
civilian
attempted
to
give
Narcan
or
naloxone
to
somebody.
This
would
be
documented
in
this,
and
then
we
could
see
how
many
people
were
affected
again,
not
official.
That
goes
to
the
coroner's
office
for
all
that.
C
What
we'll
see,
though,
is
how
it
is
detailed,
is
we
put
down
an
address
that
address
is
encrypted.
Nobody
can
see
it,
but
then
you'll
see
all
those
different
addresses.
Excuse
me,
I
should
say
diamonds
or
circles
throughout
the
county
map
indicating
the
jurisdiction.
Of
course,
we've
had
deaths
in
every
jurisdiction
law
enforcement,
jurisdiction,
primarily
the
larger
jurisdiction
for
a
boulder
Lafayette
Longmont,
and
a
few,
the
19th
and
20th
of
this
month,
Boulder
County
did
have
two
fatal
suspected
overdoses,
Boulder
police
police
department
had
nine
incidences
since
the
10th
and
thank
gosh.
C
C
That
is
the
general
gist.
First,
on
what
OD
map
is
and
with
this
live
data,
Public
Health
other
treatment
and
prevention
agencies
can
use
that
information
to
find
out
where
there
are
places
are
occurring,
maybe
even
more
so
the
frequency
and
maybe
think
of
ways
to
tackle
this
and
think
ahead
for
giving
things
such
as
we've
talked
about
vending
machines
in
different
locations.
C
C
So
on
this
I
want
to
give
you
a
little
bit
of
information
on
the
trends
that
we've
been
seeing
lately
for
the
past
few
years,
and
right
now,
I'm
going
to
talk
about
those
m30
pills.
Those
are
the
ones
that
are
suspected
to
be
containing
fentanyl
when
they
have
been
past
a
few
years,
we've
been
seeing
a
cost
on
the
street
between
five
and
twenty
dollars
right
current
cost
now
is
drastically
lower.
C
You
can
easily
find
these
pills
even
two
dollars
or,
if
you
buy
in
the
bulk,
unfortunately,
you
can
get
it
even
cheaper.
Why
it's
supply
and
demand
and
everything
with
our
these?
How
should
I
say
these
cartels?
C
These
cartels
are
getting
very
good
at
the
distribution
Network
that
they
have.
They
are
very
efficient
and
with
more
time
as
they
go,
they
pick
up
more
drug
traffickers
and
drug
dealers
to
sell
their
product.
Their
Wares
in
any
state
Colorado,
of
course,
is
one
of
them,
a
large
amount,
of
course,
because
the
supply
and
their
distribution
is
coming
up
primarily
from
Mexico
and
coming
up
towards
our
location.
C
Other
competition
to
keep
the
prices
low,
of
course,
is
the
different
drug
trafficking
organizations
around
the
state,
but
also
there
is
person-to-person
dealing
and
then,
of
course,
there's
the
internet,
which
you've
been
hearing
about
very
frequently
that
also
drives
costs
down.
C
One
of
the
other
drugs
that
you've
probably
heard
about
as
well
is
xylazine.
This
is
getting
the
West
Coast
the
east
coast
and
it
will
come
to
Boulder
County.
We
have
not
seen
xylazine
yet
in
any
Coroner's
reports,
but
I
can
guarantee
you.
Unfortunately,
that
is
coming.
Xylazine
is
a
animal
tranquilizer.
C
C
They
give
both
a
very
similar
effect.
But
if
you
give
Narcan
to
somebody
who
is
on
the
opioid
and
the
xylazine,
the
opioid
excuse
me,
the
Narco
naloxone
will
assist.
Hopefully,
Reviving
The
person
reference
the
opioid,
but
it
has
no
effect
at
all
on
the
xylazine,
because
it's
a
tranquilizer,
and
that
is
why
it's
so
imperative
that
people
still
get
medical
treatment,
because
whether
the
naloxone
wears
off
or
the
xylazine
is
not
treated,
people
can
die
if
I
did
not
mention
it.
C
There's
been
four
overdoses
in
the
Denver
area
that
are
associated
with
xylazine,
none
here
frequent,
not
in
Boulder
County
frequent
names
that
you
have
that
you'll
hear
on
the
street.
The
primary
one
is
trench
and
that's
because
it
is
a
tranquilizer.
C
Then
I
want
to
touch
a
little
bit
about
what
we're
also
seeing
down
here
on
cases
that
Boulder
County
has
had
months
ago.
We
had
an
active
excuse
me
months
ago.
C
C
We
currently
have
active
prosecution
against
multiple
different
people
as
well,
some
of
which
are
for
manslaughter
partnering
with
the
DA's
office
and
then,
lastly,
last
last
month
or
excuse
me
last
week,
you
might
have
heard
of
the
prosecution
of
a
Longmont
gentleman
last
of
first
of
tan,
tan,
first
and
last
of
tan
tan,
he
was
convicted
on
multiple
charges,
drug
charges
containing
or
related
to
Fentanyl
and
methamphetamine.
C
Why
I
say
this
is
important,
is
because
the
equipment
that
was
successful
or
helped
in
the
conviction
of
these
people
are
is
the
equipment
that
I've
asked
for
with
the
opioid
litigation
fund,
the
approximate
ninety
five
thousand
dollars
a
year
out
of
each
year?
It's
looking
like
at
1.7
mil
we're
doing
95.
C
This
is
helping
the
community
members
around
Boulder
County,
giving
a
successful
prosecution.
Now
I
gave
you
a
whole
world
with
this
stuff
and
I
passed
over
some
things
that
you
might
have
questions.
So
is
there
any
questions
that
I
can
answer
or
any
research
I
can
find
out
and
get
the
answer
for
you.
D
B
It
hasn't
been
sent
out
yet,
but
I
can
send
them
afterwards.
Yeah
and
I
know
Nico
and
me
you
could
probably
speak
more
to
this.
It
was
it
wasn't
populated
with
any
localized
data,
so
it
was
mostly
just
yeah,
so
it
was
sort
of
more
of
a
static
image
to
show
you
what
OD
map
is,
but
it
I'm
not
sure
it
had
any
actual
data
on
it.
No.
C
I
I
did
not
I
did
not
have
the
data
on
there
that
there's.
We
cannot
give
people
access
or
see
that
it's
it's
just
the
the
contract
we
have
with
odmap
the
partnering
agencies,
law
enforcement,
coroner's
office,
DA's,
Boulder,
County,
Public
Health
will
be
able
to
see
that
data.
When
they
are
all
signed
up,
then
they
can
share
that
information
with
the
preventative
and
treatment
facilities.
All
over
right,
saying,
hey,
we've
had
a
high
rise
of
something
occurring
in
this
area.
C
Let's
come
up
with
a
plan
to
battle
that
and
see
what
we
can
do,
but
yeah
you
will
not
see
that
and
I
want
to
focus
again
is
you
will
not
see
addresses?
You
will
not
you'll
see
very
very
general
areas
where
an
overdose
occurred
of
some
sort
right.
It
does
not
delve
down
into
the
minutia
of
the
address
of
at
1234.
Main
Street
never
gets
like
that,
and
it's
also
encrypted.
So
no
one
that
information
never
comes
out.
D
And
this
is
just
a
second
quick
question:
it's
a
little
bit
naive,
probably
on
my
part,
but
just
as
far
as
the
Law
Enforcement
cases
I'm,
assuming
these
are
all
direct
distribution
cases
and
that
I
understand
that
law
enforcement
is
probably
looking
for
the
source.
How
often
are
they
successful
in
in
finding
the
source,
whoever
is
making
the
drug
and
and
has
a
broader
distribution
of
it.
C
And
that's
a
that's!
A
good
and
hard
question
time
is
life
and
I
mean
that
seriously?
If
we
can,
let's
say
hypothetically,
we
can
get
a
phone
from
a
victim
or
we're
able
to
arrest
the
drug
dealer
and
get
into
his
or
her
phone
quickly.
C
C
A
Nico
I
know
it's
it's
early
in
the
game
and
I
know
you
don't
have
a
crystal
ball
but
I
wonder
if
the
increase
in
overdoses
is
indicating,
you
know
a
potential
increased
threat
and
will
we
see
more
and
is
that
what
the
law
enforcement
agencies
are
worried
about
and
is
there?
Is
there
a
call
to
action
related
to
that
Beyond?
What's
already
happening.
C
C
There
are
more
back
there
right,
so
the
law
enforcement
part
of
this
is
we
will
never
stop
the
drugs
from
coming
in,
prevent
to
me
means
stop.
We
will
not
prevent,
we
will
lessen
the
amount
of
drugs
coming
into
our
community,
meaning
we
will
lessen
the
chance
that
somebody
could
die
or
give
a
better
chance
at
less
people
will
die.
If
that
answered
your
question,
but
it
is
never
ending.
A
Are
there
any
other
questions
for
Nico
or
wonder
if
anyone
wants
to
share
their
perspective
and
observation?
What's
happening
locally,
that
you're
seeing
and
then
the
final
question
Kelly
and
I
had
is
around?
Are
these
sorts
of
updates
useful
and
how
often
should
we
be
bringing
them
forward?
I
think
the
secondary
interest
on
our
part
is
again
just
putting
real
time
names,
not
people's
names,
but
that
these
are
people's
lives.
A
E
Yeah
Nico,
thank
you
so
much.
This
was
a
really
helpful
presentation
and
I
think
we're
already
seeing
the
dividends
of
investing
in
the
OD
map
collaboration.
We've
recently
had
some
unfortunate
incidents,
as
you
mentioned
in
our
community
and
from
public
Health's
perspective.
E
Recognizing
that
needs
may
change
over
time
that
it's.
This
is
a
very
Dynamic
space
and
that
new
needs
are
occurring
and
we
may
find
that
new
Solutions
are
needed
to
as
we
begin
to
move
into
response
modes
more
quickly.
But
thank
you
very
much
for
this.
It's
beginning
of
what
what
I
hope
will
be
a
really
useful
tool
for
us.
C
You
bet,
one
thing
I
did
forget
is
to
inform
you.
We
started
inputting
data
into
OD
map
September
of
last
year,
so
I
can't
give
anyone
a
real
comparison
on
what
it
last
year
was
compared
to
this
year.
The
only
thing
we
could,
unfortunately,
do
is
look
at
the
numbers
from
the
coroner's
office,
but
this
is
the
first
great
year
where
all
the
agencies,
putting
in
that
information,
will
help
give
you
guys
a
road
map
of
where
we
are
live
time
for
the
decisions
that
you
make.
A
Sounds
like
there's
consensus
about
reviewing
this
data
and
maybe
we'll
start
with
quarterly,
and
then,
if
we
have
you
know
some
explosion
or
emerging
issues
that
come
up
between
those
borders,
we
could
bring
it
to
the
board.
B
Okay,
so
next
up,
we
did
want
to
review
a
conversation
that
we
had
started
in
our
March
Rock
meeting
around
the
possibility
of
doing
some
testing
of
the
County's
waste
water.
To
see
sorry
I
keep
getting
email
alerts
to
see
if
there's
any
Rising,
Trends
spikes
prevalence
that
we
can
sort
of
zero
in
on
particular
hot
spots
of
opioids
that
are
kind
of
coming
up
in
the
Wastewater,
and
so
just
a
quick
reminder
of
what
this
project
entails.
B
So
the
background
is
really
that
Wastewater
testing
has
been
an
ongoing
effort,
and
specifically,
during
the
pandemic,
there
was
an
increase
in
testing
Wastewater
to
identify
communicable
diseases
such
as
covid
the
hot
spots,
the
trends
again
sort
of
spikes,
so
that
we
could
figure
out.
You
know,
are
there
areas
that
we
want
to
Target
our
resources
or
have
really
targeted
initiatives,
or
how
do
we
we
evaluate
what's
going
on
over
time,
so
that
translates
forward
to
today
when
this
technology
is
really
being
expanded
to
test
for
opioids
within
Wastewater?
B
And
so
what
that
might
look
like
is
you
know,
fentanyl
traces
coming
up
to
identify
where
you
know
where
these
drugs
are
appearing
within
our
community,
and
that
could
point
us
in
the
direction
of
having
a
more
tailored
approach
to
sort
of
tackling
that
in
those
specific
areas.
So,
after
our
March
discussion
or
I
should
say
during
our
March
discussion,
really
the
charge
from
the
council
was
you
know
to
to
go
and
investigate
this
a
little
bit
further
and
see?
What
are
we
really
talking
about
in
terms
of
scope?
B
Opportunities,
bring
back
some
use
cases.
So
where
is
this?
Actually,
this
testing
being
done
to
identify
opioids
in
Wastewater
and
what
are
what
are
localities
doing
with
this
information?
So
a
little
bit
more
of
the
answer
to
you
know
to
what
end
and
then
bring
back
an
understanding
of
Financial
and
staff
capacity
that
might
be
required
to
launch
or
stand
up
an
initiative
like
this
and
then
finally,
The
Rock
provided
the
feedback
that
they
would
like
this.
To
also
be
a
conversation
that
the
opioid
operations
group
holds,
and
we
are
meeting
this
Thursday.
B
So
we
can
carry
forward
both
the
March
and
today's
conversation
to
that
group
for
subsequent
discussion.
So
really
with
that
charge,
we
went
and
investigated
with
two
primary
sources,
both
biobot,
which
is
the
MIT
based
organization.
That
really
leads
and
is
advancing.
The
use
of
this
testing
technology,
as
well
as
our
local
or
I,
should
say
our
state
Partners
up
at
Colorado,
Department
of
Public,
Health
and
environment
cdphe,
and
so
before.
B
We
kind
of
go
into
those
two
two
viewpoints
just
wanted
to
have
a
slight
caveat
and
mention
that
this
is
definitely
a
conversation
with
many
different
perspectives
and
points
of
view
and
really
just
kind
of
again
Echo
that
we're
bringing
forward
this
information
from
a
neutral
perspective,
so
that
council
members
can
feel
more
informed
in
having
a
conversation
of
whether
or
not.
This
is
a
good
fit
for
Boulder
County
to
pursue.
B
So,
first
up
the
summary
that
we
got
from
our
partners
at
cdphe
was
that
this
is,
you
know,
potentially
an
opportunity,
but
there's
some
some
serious
sort
of
drawbacks
to
to
be
considerate
of
for
cdphe
itself.
As
an
agency,
there
are
some
funding
restrictions,
so
the
centers
of
Disease
Control
at
the
federal
level,
are
not
allowing
cdphe
to
fund
any
efforts
around
Wastewater
testing
for
or
for
opioids.
B
So
at
this
time
it
doesn't
seem
like
there
is
any
clear
path
for
how
to
fund
or
sustain
this
effort,
should
cdphe
determined
to
take
that
on
also
some
Express
concerns
around
the
drawbacks
to
the
testing
capabilities,
so
some
ethical
concerns
around
whether
or
not
it
would
stigmatize
certain
neighborhoods
or
regions.
If
we're
really
drilling
down
to
see
that
you
know,
opioids
are
spiking
within
said
region
or
neighborhood.
So
a
few
concerns
about
what
that
might
do
at
that
ethical
level.
B
There's
also
some
concern
that
this
is
not
really
tested
proven
vetted
quite
enough
in
order
for
it
to
really
be
tied
to
any
cohesive,
Public
Health
response,
either
at
the
state
level
or
any
of
the
sort
of
local
levels
of
Public
Health
Initiative.
In
response
also,
some
concerns
that
testing
for
opioids
in
Wastewater.
It
doesn't
allow
us
the
ability
to
distinguish
between
valid
use
of
opioids
that
might
be
showing
up
in
the
Wastewater,
such
as
prescriptions
versus
invalid
or
illicit
use.
B
So
again,
some
concern
that
we're
not
really
going
to
be
able
to
get
at
that
question
of
you
know
to
what
end.
What
is
this
data
really
telling
us,
and
what
can
we?
How
is
it
meaningful
and
how
can
we
act
on
it,
and
there
was
also
some
conversation
about
alternative
testing
sources,
so
we
do
know
that
state
has
surveillance
data
that
has
been
in
use
by
our
Public
Health
Partners.
B
We
also
know
that
there
are
improvements
coming
to
various
State
data
about
excuse
me,
dashboards
data
dashboards,
both
the
cdphe,
as
well
as
the
Consortium
for
prescription
drug
abuse
prevention,
are
building
out
more
of
the
indicators
that
are
reflected
on
their
data
dashboards
that
speak
to
use
potential,
abuse
of
opioids
and
sort
of
different
prevalence
trends
that
you
know
this
is
a
source,
that's
already
current
and
present
in
in
use
by
our
Public
Health
Partners
today.
B
So
just
some,
some
hesitancy
there
from
cdphe
and
I'll
actually
just
deliver
the
the
feedback
from
biobot
as
well,
and
then
we
can
kind
of
pause
for
questions
and
see
once
we've
taken
it
as
a
whole.
I
think
that
probably
makes
the
most
sense.
B
So
the
opposing
side
of
this
conversation,
I
shouldn't,
say
opposing
but
different
perspective
is
biobot.
So
again,
biobot
is
the
testing
and
research
organization
housed
out
of
MIT,
that's
really
kind
of
leading
the
charge
and
using
this
technology
to
test
Wastewater
for
a
number
of
different
communicable
diseases,
as
well
as
fentanyl,
traces
and
other
opioids.
So
you
know
just
kind
of
the
brass
tax.
B
First
and
foremost,
the
cost
of
this
service
would
be
approximately
50
000
per
year
per
location,
so
that
location
would
really
be
the
number
of
Wastewater
facilities
that
we
have
in
Boulder
County.
That
would
include
weekly
testing
of
the
Wastewater.
It
would
also
include
program
support,
so
there's
a
various
there's,
various
capacities
that
they
sort
of
bring
in
their
team
to
assist
in
not
just
delivering
the
data,
but
helping
us
to
incorporate
it
into
our
activities.
B
Our
strategies,
how
we
communicate
to
our
our
partners
in
our
community
Etc,
our
app,
also
biobot
sort
of
sees
the
the
stigma
lens
a
little
bit
differently,
so
noting
that
many
of
their
Partners
actually
choose
to
do
Wastewater
testing,
because
it
is
anonymous,
and
it
is
one
of
the
ways
that
we
can
figure
out.
What's
going
on
enough
at
a
local
level
that
we
can
drill
down
and
have
targeted
interventions.
B
However,
at
the
end
of
the
day,
there
are
enough
individuals
within
a
community
feeding
a
particular
Wastewater
Plant
that
it's
it's
essentially
Anonymous
at
that
sort
of
individual
level
staff
capacity.
So
this
was
a
question
that
the
the
council
member
members
brought
forward
and
just
said
what
would
it
look
like
to
actually
participate
in
this
concept?
B
So
primarily
the
capacity
falls
on
the
Wastewater
testing
staff
to
pull
the
actual
samples
and
then
mail
them
into
biobot
in
discussion
with
their
team.
They
mentioned
that
you
know
this
is
part
of
the
everyday
workflow
of
folks
at
the
Wastewater
facilities,
already
they're
they're,
drawing
these
samples
on
an
ongoing
basis
and
sending
them
into
various
compliance
agencies,
and
so
they
have
not
found
this
to
be
of
any
strain
to
current
wastewater
treatment,
plant
staff
and
then
in
terms
of
County
staff.
B
So
we
did
ask
you
know
how
would
this
be
accompanied
or
supplemented
by
you
know
staff
should
the
county
take
it
on,
and
they
said
that
their
team
does
typically
work
with
a
program
manager
who
sort
of
leads
the
effort
and
pulls
all
the
pieces
together,
as
well
as
an
epidemiologist,
usually
out
of
the
public
health
department
that
helps
kind
of
Drive
the
data
into
again.
B
That's
that
that
public
health
response-
or
you
know,
ties
it
to
our
initiatives
and
strategies
and
also
provides
a
little
bit
more
of
the
local
context
to
the
data.
B
So
in
terms
of
use
cases,
this
was
another
question
that
we
had
the
rock
ask
about.
So
biobot
is
doing
Wastewater
testing
in
400,
400
locations,
250
counties
and
all
50
states.
So
we
did
pull
forward
just
a
couple
of
use
cases
so
to
speak
to
in
Marin
County
California.
B
They
are
currently
using
this
testing
to
identify
opioid,
spikes
and
Trends,
and
they
too
have
sort
of
pitched
their
use
of
this
technology
as
something
that
is
reducing
stigma
and
an
approach
that
will
actually
allow
them
to
drill
down,
but
without
actually
looking
at
data
that
is
not
anonymized,
so
in
Cary
North
Carolina.
They
are
looking
at
this
at
a
neighborhood
level
and
also
utilizing
the
information
to
have
very
targeted
interventions
within
those
specific
neighborhoods.
B
The
CDC
Centers
for
Disease
Control,
National
Wastewater
surveillance
system,
as
well
as
U.S
HHS,
are
also
using
this
technology
right
now
to
continue
the
the
monitoring
of
communicable
diseases
and
spread
of
those
diseases
in
certain
areas.
B
So
I
think
it
was
HHS
that
had
set
in
their
press
release
that,
as
the
clinical
data
sort
of
decreases
around
communicable
diseases
like
covet
or
monkey
pox
that
there's
actually
the
ability
to
draw
more
usable
data
from
these.
That
would
these
sources
that
would
allow
us
to
still
monitor
traces
and
prevent
Resurgence
of
of
those
diseases.
D
Hand
up
yeah
Kelly
thanks
so
much
for
digging
into
the
details
around
this.
It's
really
interesting
and
I
appreciate
the
the
statement
around
kind
of
the
stigma,
stuff
and
I
think
it's
something
we
run
into
with
any
geographical
mapping
that
we
do
is
we
have
to
be
really
careful
about
how
we're
messaging
things
and
how
we're
using
the
data.
That's
that
feels
really
important,
regardless
of
what
what
data
we
have
I'm
interested
in
you
know
the
Marin
County
and
Cary
North,
Carolina
and
kind
of
their
targeted
interventions.
D
I
think
it's
you
know
something
we're
trying
to
do
across
a
lot
of
the
work
is,
is
how
do
we
stretch
the
dollars
that
we
have
and
and
really
Target
our
inventor
our
investments
to
try
to
to
get
to
the
people
who
are
in
in
the
most
need
and
I
see
that
the
same
in
this
area?
So
it's
it's
really
interesting
and
I
appreciate
also
the
flip
side
of
some
of
the
complications
and
the
expense
and-
and
it's
not-
it's
not
perfect,
either,
but
really
appreciate
the
details.
B
Yeah
and
I'd
be
happy
to
get
more
information
about
these
three
use
cases
and
the
specific
sort
of
interventions
that
they
put
in
place
around
this
data.
If
that
would
be
helpful
to
kind
of
flesh
out
that
picture
a
little
bit
more.
D
Yeah
I
mean
I,
do
I
appreciate.
The
other
side
of
this,
though,
is
that
there
is
prescribed
opioids
that
are
going
to
show
up
as
well
and
there's
no
way
to
know
the
difference,
but
I
you
know,
is
there
something
about
that
that
can
lead
to
you
know,
use
or
abusive
of
illegal
drugs?
You
know
because
they're
so
addictive
and
if
you
know
even
targeted
interventions
for
those
for
those
people
or
those
neighborhoods
could
benefit
them
in
the
long
term.
Potentially.
A
E
Thanks
yeah
Kelly
I'm,
hoping
you
might
be
able
to
clarify
Susan's
Point
real
quick
I've
heard
conflicting
reports
on
whether
the
technology
can
distinguish
between
prescription,
opioids
and.
E
Other
illegal
use,
opioids
or
kind
of
street
drugs,
I
and
I-
don't
know
the
answer
to
it,
but
some
folks
that
I
have
had
conversation
with
have
said.
Actually
the
technology
can,
just
you
know,
distinguish
between
many
different
types
of
fentanyl,
for
instance.
E
The
other
question
I
have
is
what
I'm
seeing
on
your
slide
is
that
the
use
cases
include
in
all
50
states
and
I'm
curious.
If
you
know,
is
there
a
group
in
Colorado,
that's
been
using
Wastewater
treatment
tracking
for
opioids.
B
I
don't
know
if
there
is
specifically
a
group
in
Colorado
I
do
know
that
the
biobot
team
mentioned
that
they
were
working
closely
with
the
coax
at
the
Attorney
General's
office
to
see
if
there
were
opportunities,
so
it
seemed
like
there
was
starting
conversation
around
the
potential
partnership
to
really
kind
of
move
into
this
space.
B
I
know
that
some
of
the
conversations
they
had
mentioned
were
a
little
bit
more
focused
on
Denver
as
a
region,
so
probably
just
trying
to
to
kind
of
enter
the
state
through
the
most
populated
Zone
first,
but
I'd
be
happy
to
find
out.
If
there
are,
you
know,
some
of
those
are
captured
within
I
would
assume
if
all
50
states
are
reflected.
There's
some
in
Colorado,
so
I'm
happy
to
figure
out
some
more
there.
I
will
say
a
majority
of
the
county
level
ones.
B
When
I
did
look
were
in
the
state
of
California
and
I
I,
don't
know
any.
You
know
any
inference
of
what
that
means,
but
I
know
that
they
have
a
strong
presence
in
the
state
of
California.
A
Ahead,
Maria
I
just
put
a
thing
in
the
chat,
but
she
also
passed
along
that.
Csu
has
developed
an
assay
for
22
opioids
and
Other
Drugs,
including
Fentanyl.
A
She
thought
I
don't
want
to
speak
for
her,
but
what
she
mentioned
was
she.
She
thought
that
one
sample
site
for
these
22
would
cost
a
thousand
per
sample,
so
that's
considerably
less
expensive
than
the
biobot,
so
Kelly,
maybe
that's
something
that
you
could
follow
up
on
as
well.
B
Yeah
for
sure,
happy
too
and
I
should
clarify
too
some
of
these
use
cases.
You
know
I
I,
see
it
says:
50
states
reflected
not
all
of
them.
These
are
use
cases
around
use
of
this
technology
for
opioid
testing.
So
you
can
see
like
the
CDC
example.
That's
what
I
included
that
one
is
really
they're
still
using
this
primarily
for
identifying
the
spread
of
or
prevalence
of
communicable
diseases
and
sort
of
in
that
consideration.
Phase
about
extending
that
use
outward.
So
just
a
point
of
clarification.
B
E
B
I
also
realized
Lexi,
I,
didn't
answer
your
first
question
about
the
prescription:
drug
prescription,
opioids
I,
don't
know
the
answer
to
that.
One
I
know
when
we
spoke
to
them.
They
really
focused
on
fentanyl
as
something
that
they
can
pull
forward
and
so
I
think
that
was
really.
You
know
in
an
implied
indication
of
more
of
an
illicit
sort,
but
I
don't
know
if
that's
maybe
just
me
trying
to
make
that
connection.
I
am
happy
to
dig
into
that
a
little
bit
further
and
see
what
the
sort
of
capability
is.
There.
A
I
think
the
at
this
point
we're
not
going
to
make
a
decision
either
to
both
go
forward
or
not
I.
Think
the
the
decision
I
would
like
to
hear
from
the
board
is
whether
this
is
worth
continuing
to
use
staff
time
to
explore
to
get
the
opioid
operations
groups
feedback
as
well
it.
A
It
feels
to
me
and
I
may
be
wrong
check
me
on
this-
that
there's
still
enough
curiosity
about
it
and
again,
I
think
I
think
we're
all
grappling
with
you
know,
who's
being
impacted
and
then
what's
our
response,
whether
it's
some
sort
of
you
know
campaign
or
directing
resources
to
a
specific
neighborhood
or
recognizing
the
issues
of
stigma.
A
So
I
just
wanted
to
check
that
with
the
group
and
see
if
there's
a
thumbs
up
to
move
ahead
with
exploration
or
if
people
feel
like
you
have
enough
information
to
to
make
a
determination
given,
given
that
commissioner
Levy
and
Maria
are
not
available
today,
I
I
would
table
a
final
vote,
even
if
you
feel
like
you're
ready
to
make
that
decision
today.
A
Susan
was
your
thumbs
up
to
continue
exploring
yeah
yeah.
Any
other
comments.
E
A
So
Kelly
I
think
to
continue
to
explore
and
yeah.
You
know
again:
I
want
to
support
your
Your
Capacity
in
terms
of
what
you
might
need
and
to
to
continue
this
work,
and
you
and
I
can
just
keep
in
touch
about
that
sure.
B
Yeah,
no,
that's
really
helpful.
I
think
you
know
having
these
really
specific
questions
come
forward.
Is
it
kind
of
streamlines
that,
because
we're
able
to
kind
of
be
in
communication
with
these
teams
now
and
just
get
right
to
the
Brass
tax
of
what's
most
interesting
for
council
members
to
hear
a
little
bit
more
about
so
it's
great.
B
Any
other
questions
before
we
move
on
okay,
so
another
update
to
a
conversation
that
we
started
in
our
March
Rock
meeting
is
around
our
selection
process
for
an
agency
that
might
assist
us
with
some
facilitation,
Community
engagement,
strategic
planning
and
evaluation
around
our
opioid
abatement
strategies,
so
just
wanted
to
give
a
snapshot
of
the
process
so
far.
Some
of
this
is
a
little
bit
repeat
from
last
time,
but
some
of
it
is
new.
B
Since
then
we
did
receive
six
responses
to
the
request
for
proposal
and
we
did
take
a
first
dab
at
the
initial
grading
by
staff.
We
took
summaries
of
four
of
those
six
remaining
that
we
thought
were
worth.
You
know
having
the
operations
group
weigh
a
little
bit
more
in
on.
We
brought
those
summaries
to
the
Ops
group
in
March
and
we
had
some
discussion
around.
What's
the
preferred
approach
of
this
group,
what
are
some
next
steps
that
the
group
sees
as
relevant?
B
Then
we
had
a
similar
conversation
in
our
last
meeting
together
and
just
kind
of
carried
forward.
Some
additional
questions
that
rock
members
did
want
to
see.
These
finalists
agencies
speak
to
in
a
little
bit
more
detail.
B
Three
of
those
agencies
were
moved
forward
to
interviews
except
around
the
conversation
and
questions
that
came
forward
from
both
the
Ops
group,
as
well
as
the
The
Rock.
We
also
allowed
participation
from
Ops
group
members
or
I
shouldn't,
say
a
loud
welcomed,
opscript
participation
in
those
interviews
and
provided
recordings
of
the
interviews
back
to
the
full
group
afterwards.
So
if
you
were
able
to
also
weigh
in
who
were
not
able
to
attend
those
interviews
but
still
wanted
to
to
kind
of
weigh
in
on
the
on
the
agencies,.
B
So
these
are
the
three
finalist
agencies
that
continued
to
the
interview
process
and
really
the
conversation
that
we
had
in
these
interview
process
or
excuse
me
in
these
interviews-
was
the
questions
that
this
group,
as
well
as
the
Ops
group,
carried
forward
about
Community
presence.
What
is
the
opportunity
or
plan
for
their
staff
and
their
agency
to
be
present
in
the
community?
B
How
do
they
plan
to
sort
of
engage
community
members
and
have
a
local
context,
because
if
you
can
recall,
many
of
these
agencies
were
from
based
out
of
states,
and
so
we
knew
that
that
was
something
that
was
really
important
to
hear
more
about
evaluate
evaluation
techniques.
So
all
three
of
these
programs
did
apply
for
both
the
facilitation
piece,
as
well
as
the
evaluation
piece
of
the
RFP.
B
So
we
did
want
to
hear
some
specific
questions
around
evaluation
technique
and
the
approach
to
measure
impact
across
not
just
the
programs,
but
also
the
suite
of
programs
as
a
whole.
We
also
wanted
to
hear
more
from
the
staff
that
would
be
on
the
project
and
so
welcomed
each
of
these
teams
to
bring
any
of
their
staff
members.
That
would
be
involved
in
the
process
forward,
so
they
could
speak
a
little
bit
more
to
their
sort
of
touch
on
the
project
and
their
their
credentials
and
experience
and
similar
work.
B
B
So
our
recommendation
at
this
time
is
to
move
forward
with
third
Horizon
strategies,
so
really
the
the
strengths
that
came
out
for
third
Horizon
were
multiple,
the
first
and
foremost
they
do
have
a
local
presence.
They
have
staff
that
will
be
leading
this
project
that
live
in
the
Denver
metropolitan
area.
B
They
are
well
versed
and
immersed
in
the
koak
and
the
opioid
abatement
efforts
at
the
state
level
with
the
Attorney
General's
office,
so
they
were
able
to
reflect
a
really
strong
understanding
of
what's
going
on
both
locally
and
nationally
around
opioid
abatement.
We
also
received
some
really
strong
references
from
the
references
that
they
put
in
their
RFP,
particularly
I
wanted
to
call
forward
that
they
were
one
of
their
references
mentioned
that
there's
they.
B
They
thought
that
their
biggest
strength
was
in
their
Community
engagement
approach
and
having
a
really
meaningful
stakeholder
engagement
process
and
really
being
intentional
about
how
they
folded
in
stakeholder
input
into
any
recommendations
or
products
that
they
created.
So
we
I
thought
that
was
pretty
important
to
reflect
since
it's
come
up
so
many
times
in
conversation
with
the
operations
group,
as
well
as
this
Council.
B
In
terms
of
their
evaluation
methods,
they
were
able
to
speak
to
sort
of
a
mixed
method
approach,
which
was
really
great
so,
first
and
foremost
knowing
and
utilizing
any
of
the
data
sources
that
are
already
available
within
our
region,
as
well
as
looking
into
other
investigative
work
projects,
groups
that
are
doing
similar
sort
of
Investigations
so
that
they
can
tie
these
efforts
together
again.
That
collaboration
piece
is
it's
something
we
heard
come
forward
as
a
a
priority
or
value
both
from
this
group
and
the
operations
group.
B
Also
they.
They
were
very
intentional
about
being
aware
of
the
state's
reporting
requirements
and,
what's
or
at
least
the
timeline
for
which
we'll
be
hearing
a
little
bit
more
about
the
state's
reporting
requirements
and
how
they
plan
to
sort
of
roll
that
into
their
evaluation
technique.
They
also
wanted
to
base
their
evaluation
on
a
strong
understanding
of
each
intended
impact
of
each
in
each
individual
program.
B
So
you
know
they
were
able
to
reflect
this
understanding
that
each
of
these
programs
are
going
to
be
held
to
a
different
level
of
outcome
process
outcomes
Etc
based
on
what
they're
really
hoping
to
achieve.
But
then
also,
how
are
we
tying
those
outcomes
and
evaluation
of
those
outcomes
into
a
broader
picture?
And
then
they
also
were
really.
You
know,
conscious
of
speaking
about
this
from
a
system
level,
so
you
know
ways
and
methods
that
they
would
illuminate
system
gaps.
A
I
just
want
to
remind
the
group
that
the
board
did
did
say
that
we
would.
We
supported
staff
in
the
Ops
group
to
make
the
recommendation,
but
we're
interested
in
if
there's
any
concerns
or
other
things.
That
you'd
like
to
note
before
we
proceed
with
Contracting.
E
Sorry,
I'm
always
just
a
little
bit
late
to
the
game.
Kelly
I'm
just
wondering
if
you
have
any
insight
and
additional
information
on
the
point
about
their
local
presence
and
handle
on
local
context.
If
you
could
share
that.
B
Yeah,
so
their
lead,
investigator,
Mindy,
I,
I,
believe
it's
cloud
in
or
cloudman
I
apologize
for
losing
sight
of
the
last
name.
She
lives
in
Denver,
she's,
been
local
to
Denver
area
for
a
while
and
has
been
involved
in
opioid
abatement.
Work
addiction,
work,
research
around
recovery
systems
across
Colorado,
so
it's
I'm
happy
to
get
a
little
bit
more
information.
Those
are
the
things
that
really
stick
out
for
me.
B
I
know
that
the
local
presence
was
something
that
you
know.
Both
groups
really
echoed
was
super
important.
Mindy
was
able
to
speak
to
how
they
plan
to
budget
to
be
in
person
for
specific
meetings,
specific
meetings
that
they
knew
would
be
better
to
lead
in
person
versus
ones
that
they
thought
could
potentially
be
facilitated
virtually.
E
A
Ellie
I
just
wanted
to
thank
you
and
commend
you
another
staff,
as
well
as
the
Ops
group
who
participated
in
this
process.
That
seemed
really
thorough
and
thoughtful.
So
so
thank
you
for
bringing
this
recommendation
forward.
Yeah.
B
Absolutely
we're
excited
to
get
working
with
them.
We
know
we
have.
We've
got
a
lot
to
tackle,
so
I'm
excited
all
right,
so
I'm
gonna
go
ahead
and
move
us
forward
with
some
updates
from
the
state,
and
we
do
have
Jamie
Feld
and
Jack
Patterson
from
the
Colorado
opioid
abatement
Council,
the
Attorney
General's
office
joining
us
again,
I
believe
they
were
on
our
February
call,
so
just
to
kind
of
cue
up
some
of
the
updates.
B
So
as
a
reminder,
we
do
meet
with
the
coax
staff,
as
well
as
representatives
from
the
other
19
settlement
regions
on
a
monthly
basis
on
a
learning
collaborative
call,
and
so
just
wanted.
To
kind
of.
You
know
clue
in
the
the
group
about
some
of
the
updates
that
have
come
from
the
previous
meetings
as
well
as
what's
coming
up
in
May,
so
in
March
the
collected
used
that
meaning
to
demo
a
data
dashboard,
so
the
dashboard
really
kind
of
covers
what
each
settlement
region
is
doing
with
their
abatement
dollars.
B
What's
going
on
in
other
parts
of
the
state
in
April,
the
group
hosted
se2,
which
is
the
contractor
that
the
state
has
chosen
to
launch
a
Statewide
Public
awareness
campaign,
and
we
had
some
really
good
conversation
around
what
we
would
like
to
see
come
from
a
Statewide
campaign
and
also
what
we
would
like
to
not
see,
and
so
these
are
the
three
questions
that
we
had
some
conversation
around.
B
You
know:
what
do
you
want
to
see
in
a
campaign
what
would
be
a
deal
breaker
in
a
campaign
and
Are
there
specific
opportunities
in
your
community
where
the
campaign
could
have
a
presence,
so
good
discussion.
There
I
think
some
of
the
examples
that
came
out
were
you
know,
make
sure
that
you
have
all
of
your
resources
and
materials
in
multiple
languages
in
terms
of
some
of
the
deal
breaker
conversations,
what
stood
out
for
me
was
any
messaging
that
has
stigmatizing
or
fear-based.
B
Language
is
just
kind
of
a
deal
breaker
across
the
board,
for
you
know,
representatives
from
all
of
the
regions,
and
so
it
was
a
really
good
conversation
and
then
coming
up
in
may.
We
are
going
to
have
a
focus
on
fiscal
and
expenditure
report,
which
is
really
exciting
because
we'll
know
a
little
bit
more
about
what
our
obligations
are
in
terms
of
what
we
need
to
pull
from
our
recipient
programs
and
report
back
to
the
state
on
an
ongoing
basis.
B
Some
other
updates,
so
Jamie
had
mentioned
this
in
our
last
meeting,
but
our
settlement
amount
did
go
up
from
our
recent
settlement
from
CVS
and
Walgreens
right
now,
our
total
sits
at
approximately
30
million
still
across
that
18-year
Arc
and
then
a
little
bit
about
a
Statewide
conference
that
the
coax
will
be
hosting
every
year,
the
in
August
they
well.
B
This
will
be
the
second
year,
but
August
16th
through
18th
will
be
the
dates
for
that
conference
this
year
and
there's
a
link
if
you
want
to
provide
some
feedback
about
what
would
be
most
useful
for
you
to
hear
more
about
at
that
event.
So
that
said,
I'm
going
to
pass
it
off
to
Jamie
and
Jack
to
sort
of
expand
or
add
anything
I
missed.
F
Ellie
I
think
you
got
it
all,
so
that
was
a
great
update
and
I'll.
Let
Jack
say
if
there's
anything
more,
but
I
just
want
to
reiterate
our
appreciation
for
Boulder
County
staff
participating
so
actively
in
our
regional
forums
and
being
so
responsive.
We
also
appreciate
Boulder
County
staff,
assisting
with
the
recent
participation
forms
that
we
had
to
gather
around
the
state.
F
All
the
participation
forms
were
gathered
for
Boulder
County
region,
including
Jamestown,
which
is
notoriously
difficult
to
reach,
so
really
just
a
huge
kudos
to
your
staff
and
to
all
of
Boulder
County
for
the
act
of
collaboration,
and
please
just
let
us
know
if
there's
anything
we
can
do
for
technical
assistance.
F
We
have
a
great
team,
I'm
Jack
Patterson
who's
here
on
our
teams,
very
responsive
and
manages
our
opioids
email,
and
so,
if,
if
one
of
us
doesn't
know
the
answer,
we'll
get
you
to
the
right
folks,
I
did
put
the
link
to
our
dashboard
on
in
the
chat.
Once
we
get,
you
know
more
information
about
every
part,
we'll
we'll
let
you
know
as
soon
as
possible,
particularly
around
the
settlement
numbers,
the
expenditure
reporting
process,
but
we
we
really
are
working
front
line
with
your
Regional
primary
contacts,
which
is
Kelly
Jim
adamsberger.
F
To
relay
this
information
to
you
all
so
again,
thank
you
for
the
work
you're
doing
we're
excited
to
see
the
next
steps
with
you
hiring
this
facilitator
and
then
please,
let
us
know
you
know,
as
a
former
Boulder
County
employee
I,
just
always
love
hearing
about
the
great
work
you're
doing
so
we
look
forward
to
staying
tuned
in.
G
No
I
think
Kelly
I
think
pretty
much
all
of
our
updates
as
as
I
think
just
a
testament
to
how
engaged
Boulder
has
been
with
the
state
efforts
and
I.
Just
again
would
shout
out
both
to
Kelly,
as
well
as
to
the
to
Bob,
Halpin
and
Jim
for
all
these
sessions,
as
well
as
all
the
other
additional
support
staff
for
the
continued
partnership,
especially
with
the
opioid
salmon
forums.
So
thank
you
all
and
please
do
not
hesitate
to
reach
out
if
we
can
be
of
any
additional
assistance.
G
I
think
actually,
the
only
other
things
to
mention
are
the
state
will
be
Jamie.
If
you
want
to
touch
on
the
infrastructure
and
Innovation
part.
F
Yes,
so
we
will
be
sending
now
a
notice
through
our
newsletter
about
two
funding
opportunities.
One
is
the
infrastructure
share
and
one
is
the
Innovation
share.
F
They
have
our
Colorado
opioid
abatement
Council,
which
oversees
the
infrastructure
portion
has
made
a
slight
Amendment
to
the
policy
to
recommend
not
only
underserved
but
also
rural
communities,
for
the
infrastructure
share,
and
that
will
be
posted
early
May
and
go
out
through
our
newsletter
and
then
another
complimentary
funding
opportunity
is
the
Innovation
Grant,
and
this
is
an
exciting
new
funding.
Opportunity
that
comes
out
of
our
state
share
to
fund
Innovative
models
to
drips
the
opioid
crisis,
there's
going
to
be
three
funding,
tiers,
small,
medium
and
large
and
I
think
you
know
Boulder.
F
That
might
be
one
area
you
want
to
think
about
as
Boulder
often
Pilots
Innovative
projects
to
address
this,
you
can
include
in
why
it's
Innovative,
as
well
as
maybe,
if
you
have
any
anticipated
evaluation
to
show
how
this
could
be
replicated
in
the
state
that
will
be
also
launched
in
May
on
our
website
and
through
our
newsletter.
We'll
have
to
be
a
little
bit
radio
silence
once
it
goes.
Live
May
1st,
but
there'll
be
information
from
our
procurement
team.
F
F
A
Yeah,
just
it
just
matters
to
us
for
being
able
to
have
a
discussion
about
what
we
might
submit
and-
and
you
know
figure
it
out-
that
timing,
yeah.
F
Any
thoughts
about
that
we
they
have
not
been
finalized.
Those
due
dates,
I'd
be
curious,
is
two
months
seem
feasible
for
from
your
perspective,.
A
F
We
have
I
think
the
the
finalized
version
will
say
that
erect
that
the
letter
support
is
recommended
strongly
recommended,
but
not
required
understanding
that
a
lot
of
councils
won't
be
able
to
meet
in
that
time
frame.
And
then
the
applicant
could
put
a
reason
why
they
didn't,
but
that
is
that
is
specified
in
the
current
version
that
it's
not
required
and
that
they
could
say.
You
know,
because
the
committee
doesn't
have
time
to
meet
and
approve
prior
to
the
submission.
D
A
Great
I
don't
want
to
put
you
on
the
spot,
but
we've
got
a
previous
conversation
about
the
Wastewater
testing
for
opioids.
If
you've
been
involved
in
some
of
those
conversations,
Kelly
provided
a
great
overview
of
you,
know,
sort
of
the
pros
and
cons,
including
reaching
out
to
the
MIT
group
as
well
as
cdphe.
A
F
Hesitant
because
I
I'm
not
wearing
my
Epi,
like
my
background
as
an
epidemiologist
I'm,
not
wearing
that
hat
in
this
current
role,
I
think
my
one
thought
around
it.
Having
seen
the
response
from
cdphe
you
know
is
that
there
are
some
other
surveillance
mechanisms
that
are
already
in
place
like
the
syndromic
surveillance
that
might
not
be
fully
used
to
their
existing
potential,
and
so
you
know
sometimes
at
least
when
we
were
considering
whether
we
would
fund
it
at
the
state
level
we
thought
like.
F
Are
we
even
using
our
existing
surveillance
for
actionable
items
like
timely
syndromic
surveillance,
which
gives
you
you
know,
emergency
room
visits,
and
then
there
are
some
concerns,
I
think
with
Wastewater
around
it
not
being
able
to
differentiate
between
opioids
for
treatment
like
Suboxone
versus
opioids,
for
you
know,
misuse
or
as
prescribed
and
so
I
think
those
are
some
limitations
to
using
it
as
like
an
actionable
surveillance
tool
and
I.
Think
too.
F
The
last
thing
is
that
there
is,
you
know,
Staffing
capacity
issues
with
it,
just
as
with
any
surveillance
system,
but
I
think
it's
always
interesting
to
pursue
it
a
little
bit
further
and
I
know
yeah
Lexi
Nolan
and
your
commissioner
reached
out
to
us
when,
when
she
was
a
city,
the
mayor
of
Lafayette-
and
we
did
start
some
conversations
with
biobot,
so
always
interested
to
continue
those
conversations.
F
And
then
I
think
last
yeah
go
ahead.
Sorry,
Robin,
no
I,
just
I
was
just
thanking
you,
okay,
I
would
say.
The
last
comment
is
that
we
have
not,
at
the
state
like
finalized,
a
really
great
robust
surveillance
system,
at
least
from
the
Attorney
General's
office,
so
I
do
understand
kind
of
the
need
or
the
desire
from
locals
to
get
ahead
of
it,
because
at
the
state
we
don't
have
a
finalized
version
available.
So
I
do
understand
that
that
interest.
A
F
B
Yeah
Lexi,
it
was
around
17
million
17
and
a
half
ish
million.
A
E
A
Thanks,
everybody
for
your
continuing
engagement
and
for
the
discussion
today,
we
have
one
more
meeting
scheduled
so
you'll
be
receiving
an
email
from
me
trying
to
schedule
the
next
two
months
for
June
and
July.
It's
a
difficult
group
to
schedule,
but
I'm
always
going
to
try
my
best
to
get
at
least
two
meetings
on
the
books
at
a
time.